CRO Collaboration considerations to achieve high-quality, regulatory-compliant TMF
When sponsors choose to outsource all or certain tasks of a clinical trial to a clinical research organization (CRO), the relationship becomes critical. Since CROs have their own processes, it is critical to define what deliverables will be expected and how quality will be measured before the study begins.
This whitepaper will cover these key topics:
- Creating a cohesive partnership between sponsors and CROs
- Using data to design and define a transparent collaboration process
- Leveraging the TMF to monitor the CRO performance
- Securing the successful end-of-study transfer